Статья
Кардиомиопатия со смешанным фенотипом, ассоциированная с вариантом в гене DSP (клинико-морфологическое наблюдение и обзор сведений литературы)
Представлено описание клинического случая кардиомиопатии со смешанным фенотипом (сочетание некомпактной кардиомиопатии и аритмогенной дисплазии правого желудочка), ассоциированной с вариантом гена DSP. Первым и единственным симптомом заболевания была внезапная сердечная смерть.
1. Berger S, Utech L, Fran Hazinski M. Sudden death in children and adolescents. Pediatric Clinics of North America. 2004;51(6 SPEC. ISS.):1653–77. doi:10.1016/j.pcl.2004.07.004.
2. Шляхто Е.В., Арутюнов Г.П., Беленков Ю.Н. и др. Националные рекомендации по определению риска и профилактике внезапной сердечной смерти (2-е издание). М.: ИД “Медпрактика-М”; 2018 p. 247. ISBN 978-5-98803-397-4.
3. Kaltman JR, Thompson PD, Lantos J et al. Screening for sudden cardiac death in the young: Report from a national heart, lung, and blood institute working group. Circulation. 2011;123(17):1911–8. doi:10.1161/CIRCULATIONAHA.110.017228.
4. Maron BJ, Towbin JA, Thiene G et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16. doi:10.1161/CIRCULATIONAHA.106.174287.
5. Elliott P, Andersson B, Arbustini E et al. Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270–6. doi:10.1093/eurheartj/ehm342.
6. Towbin JA, McKenna WJ, Abrams DJ et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Hear Rhythm. 2019;16(11):e301–72. doi:10.1016/j.hrthm.2019.05.007.
7. Corrado D, Wichter T, Link MS et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement. Eur Heart J. 2015;36(46):3227–37. doi:10.1093/eurheartj/ehv162.
8. Smith W, Members of CSANZ Cardiovascular Genetics Working G. Guidelines for the Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy. Hear Lung Circ. 2011;20(12):757–60. doi:10.1016/j.hlc.2011.07.019.
9. Kapplinger JD, Landstrom AP, Salisbury BA et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia- associated mutations from background genetic noise. J Am Coll Cardiol. 2011;57(23):2317–27. doi:10.1016/j.jacc.2010.12.036.
10. Lombardi R, Marian AJ. Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: A disease of cardiac stem cells. Pediatr Cardiol. 2011;32(3):360–5. doi:10.1007/s00246-011-9890-2.
11. Лутохина Ю.А., Благова О.В., Недоступ А.В. и др. Клинические формы (классификация) аритмогенной дисплазии правого желудочка: особенности диагностики и лечения. Российский кардиологический журнал. 2018;(2):19–31. doi:10.15829/1560-4071-2018-2-19-31.
12. Thiene G, Nava A, Corrado D et al. Right Ventricular Cardiomyopathy and Sudden Death in Young People. N Engl J Med. 1988;318(3):129–33. doi:10.1056/NEJM198801213180301.
13. Гордеева М.В., Митрофанова Л.Б., Пахомов А.В. и др. Аритмогенная кардиомиопатия/дисплазия правого желудочка как причина внезапной сердечной смерти у молодых людей. Вестник аритмологии. 2012;(69):38–48.
14. Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies: Clinical forms and main differential diagnoses. Circulation. 1998;97(16):1532–5. doi:10.1161/01.CIR.97.16.1532.
15. Fontaine G, Brestescher C, Fontaliran F et al. Outcome of arrhythmogenic right ventricular dysplasia. Apropos of 4 cases. Arch Mal Coeur Vaiss. 1995;88(7):973–9. PMID: 7487328. Accessed 24 Aug 2020.
16. Arbustini E, Narula N, Dec GW et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: Endorsed by the world heart federation. J Am Coll Cardiol. 2013;62(22):2046–72. doi:10.1016/j.jacc.2013.08.1644.
17. Aras D, Ozeke O, Cay S et al. Arrhythmogenic noncompaction cardiomyopathy: Is there an echocardiographic phenotypic overlap of two distinct cardiomyopathies? J Cardiovasc Ultrasound. 2015;23(3):186–90. doi:10.4250/jcu.2015.23.3.186.
18. Полякова А.А., Крутиков А.Н., Семернин Е.Н., Костарева А.А., Гудкова А.Я. Клиническое применение классификации MOGE(S) при проведении дифференциального диагноза между идиопатической гипертрофической кардиомиопатией и ее фенокопиями. Российский кардиологический журнал. 2019;24(11):35–41. doi: 10.15829/1560-4071-2019-11-35-41.
19. Мельник О.В., Гудкова А.Я., Вершинина Т.Л. и др. Клинический полиморфизм РАСопатий в условиях детского кардиологического отделения. Cons Medicum. 2017;19(12):100–4. doi:10.26442/2075-1753_19.12.100-104.
20. Miszalski-Jamka K, Jefferies JL, Mazur W et al. Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients with Left Ventricular Noncompaction. Circ Cardiovasc Genet. 2017;10(4):e001763. doi:10.1161/CIRCGENETICS.117.001763.
21. Вайханская Т.Г., Сивицкая Л.Н., Курушко Т.В. и др. Некомпактность левого желудочка: самостоятельная кардиомиопатия или сопутствующий анатомический синдром? Кардиология. 2018;58(11S):33–45.doi: 10.18087/cardio.2558.
22. Галактионов А.А. Тропонин: норма в крови, виды тестов, причины повышения при инфаркте. https://cardiogid.com/troponin/. (24 Aug 2020).
23. Pacheco Claudio C, Quesada O, Pepine CJ et al. Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease). Clin Cardiol. 2018;41(2):185–93. doi:10.1002/clc.22894.
24. Аверков О.В., Барбараш О.Л., Бойцов С.А. и др. Дифференцированный подход в диагностике, формулировке диагноза, ведении больных и статистическом учете инфаркта миокарда 2 типа (согласованная позиция). Российский кардиологический журнал. 2019;(6):7–21. doi: 10.15829/1560-4071-2019-6-7-21.
25. Scalone G, Niccoli G, Crea F. Editor’s Choice- Pathophysiology, diagnosis and management of MINOCA: an update. Eur Hear journal Acute Cardiovasc care. 2019;8(1):54–62. doi: 10.1177/2048872618782414.
26. Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi: 10.1038/gim.2015.30.
27. Udeoji DU, Philip KJ, Morrissey RP et al. Left ventricular noncompaction cardiomyopathy: Updated review. Ther Adv Cardiovasc Dis. 2013;7(5):260–73. doi:10.1177/1753944713504639.
28. Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: Proposed modification of the task force criteria. Circulation. 2010;121(13):1533–41. doi:10.1161/CIRCULATIONAHA.108.840827.
29. Mavrogeni SI, Bacopoulou F, Apostolaki D et al. Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance. Eur J Clin Invest. 2018;48(7):e12955. doi:10.1111/eci.12955.
30. Miyake CY, Kim JJ. Arrhythmias in Left Ventricular Noncompaction. Cardiac Electrophysiology Clinics. 2015;7(2):319–30. doi:10.1016/j.ccep.2015.03.007.
31. Caliskan K, Ujvari B, Bauernfeind T et al. The prevalence of early repolarization in patients with noncompaction cardiomyopathy presenting with malignant ventricular arrhythmias. J Cardiovasc Electrophysiol. 2012;23(9):938–44. doi:10.1111/j.1540-8167.2012.02325.x.
32. Zhou H, Lin X, Fang L et al. Prolonged QTc indicates the clinical severity and poor prognosis in patients with isolated left ventricular non-compaction. Int J Cardiovasc Imaging. 2017;33(12):2013–20. doi:10.1007/s10554-017-1209-9.
33. Lahmiti S, Aboussad A. Isolated non-compaction of the right ventricular myocardium: two cases report. Ann Cardiol d’Angeiol. 2012;61(4):299–302.doi: 10.1016/j.ancard.2010.12.001.
34. Stöllberger C, Gerecke B, Finsterer J, Engberding R. Refinement of echocardiographic criteria for left ventricular noncompaction. Int J Cardiol. 2013;165(3):463–7. doi:10.1016/j.ijcard.2011.08.845.
35. Ichida F, Hamamichi Y, Miyawaki T et al. Clinical features of isolated noncompaction of the ventricular myocardium: Long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol. 1999;34(1):233–40. doi:10.1016/S0735-1097(99)00170-9.
36. Nugent AW, Daubeney PEF, Chondros P et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348(17):1639–46. doi: 10.1056/NEJMoa021737.
37. Lilje C, Rázek V, Joyce JJ et al. Complications of non-compaction of the left ventricular myocardium in a paediatric population: A prospective study. Eur Heart J. 2006;27(15):1855–60. doi:10.1093/eurheartj/ehl112.
38. Paterick TE, Jamil Tajik A. Left ventricular noncompaction: - A diagnostically challenging cardiomyopathy. Circulation Journal. 2012;76(7):1556–62. doi:10.1253/circj.CJ-12-0666.
39. Pugliatti P, Di Bella G, Recupero A et al. Non compaction cardiomyopathy and Antiphospholipid syndrome: A catastrophic thromboembolic association. Int J Cardiol. 2008;128(1):126–8. doi:10.1016/j.ijcard.2007.05.043.
40. Tenedios F, Erkan D, Lockshin MD. Cardiac Manifestations in the Antiphospholipid Syndrome. Rheumatic Disease Clinics of North America. 2006;32(3):491–507. doi:10.1016/j.rdc.2006.05.008.
41. Gabrielli FA, Lombardo A, Natale L et al. Myocardial infarction in isolated ventricular non-compaction: Contrast echo and MRI. Int J Cardiol. 2006;111(2):315–7. doi:10.1016/j.ijcard.2005.09.054.
42. Swinkels BM, Boersma LVA, Rensing BJ et al. Isolated left ventricular noncompaction in a patient presenting with a subacute myocardial infarction. Netherlands Hear J. 2007;15(3):109–11. doi:10.1007/BF03085964.
43. Correia AF, Oliveira DC, Sanctos M. Coronary Artery Thromboses, Stent Thrombosis and Antiphospholipid Antibody Syndrome: Case Report. Cardiol Res. 2018;9(2):129–32.
44. Toufan M, Shahvalizadeh R, Khalili M. Myocardial infarction in a patient with left ventricular noncompaction: A case report. Int J Gen Med. 2012;(5):661–5. doi:10.2147/IJGM.S28902.
45. Fettouhi H, Tamdy A, Ellouali F et al. Convulsives crisis revealing left-ventricular non-compaction with apical myocardial infarction. Ann Cardiol Angeiol. 2011;60(3):159–64. doi:10.1016/j.ancard.2010.12.008.
46. Güvenç TS, Erer HB, Altay S et al. “Idiopathic” acute myocardial infarction in a young patient with noncompaction cardiomyopathy. Cardiol J. 2012;19(4):429–33. doi:10.5603/CJ.2012.0077.
47. Pulignano G, Tinti MD, Tolone S et al. Noncompaction and embolic myocardial infarction: The importance of oral anticoagulation. Rev Port Cardiol. 2015;34(7-8):497.e1-497.e4. doi:10.1016/j.repc.2015.01.014.
48. Panduranga P, Mukhaini MK. Left-ventricular non-compaction with coronary artery disease. Int J Cardiol. 2011;150(1):e37-e39. doi:10.1016/j.ijcard.2009.09.476.
49. Martherus R, Jain R, Takagi K et al. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed wnt/β-catenin signaling. Am J Physiol - Hear Circ Physiol. 2016;310(2):H174–87. doi:10.1152/ajpheart.00295.2015.
50. Arbustini E, Favalli V, Narula N et al. Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy? Journal of the American College of Cardiology. 2016;68(9):949–66. doi: 10.1016/j.jacc.2016.05.096.
51. Williams T, Machann W, Kühler L et al. Novel desmoplakin mutation: juvenile biventricular cardiomyopathy with left ventricular non-compaction and acantholytic palmoplantar keratoderma. Clin Res Cardiol. 2011;100(12):1087–93. doi:10.1007/s00392-011-0345-9.
52. Tufekcioglu O, Aras D, Sahin O et al. Two cardiomyopathies in one heart. Echocardiography. 2006;23(6):519–21. doi:10.1111/j.1540-8175.2006.00253.x.
53. Wlodarska EK, Wozniak O, Konka M et al. Isolated ventricular noncompaction mimicking arrhythmogenic right ventricular cardiomyopathy - A study of nine patients. Int J Cardiol. 2010;145(1):107–11. doi:10.1016/j.ijcard.2009.05.062.
54. Стрельцова А.А., Гудкова А.Я., Костарева А.А. Некомпактный миокард: современные представления о генетических основах, клинической картине, диагностике и лечении. Терапевтический архив. 2019;91(12):90–7.doi:10.26442/00403660.2019.12.000142.
55. Li S, Zhang C, Liu N et al. Genotype-positive status is associated with poor prognoses in patients with left ventricular noncompaction cardiomyopathy. J Am Heart Assoc. 2018;7(20):e009910. doi:10.1161/JAHA.118.009910.
56. Towbin JA. Inherited cardiomyopathies. Circulation Journal. 2014;78(10):2347–56. doi: 10.1253/circj.CJ-14-0893.
57. Herren T, Gerber PA, Duru F. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: A not so rare “disease of the desmosome” with multiple clinical presentations. Clinical Research in Cardiology. 2009;98(3):141–58. doi: 10.1007/s00392-009-0751-4.
58. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, et al. Left-Dominant Arrhythmogenic Cardiomyopathy. An Under-Recognized Clinical Entity. J Am Coll Cardiol. 2008;52(25):2175–87. doi:10.1016/j.jacc.2008.09.019.